
Gene Test Service refers to services that analyze an individual's genetic material (DNA) to provide information about genetic predispositions, ancestry, or potential health risks. It involves genetic testing technologies and data interpretation.
Âé¶¹Ô´´ Analysis and Insights: Global Gene Test Service Âé¶¹Ô´´
The global Gene Test Service market is projected to grow from US$ 4075 million in 2024 to US$ 6466.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.0% during the forecast period.
The market for Gene Test Services is driven by advancements in genomics and personalized medicine. Trends include expanded test offerings, privacy-conscious practices, and integration with healthcare systems.
Report Covers:
This report presents an overview of global market for Gene Test Service market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Gene Test Service, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Gene Test Service, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gene Test Service revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Gene Test Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Gene Test Service revenue, projected growth trends, production technology, application and end-user industry.
Âé¶¹Ô´´ Segmentation
By Company
LabCorp
Quest Diagnostics
Genomic Health
NeoGenomics
Eurofins Scientific
Ambry Genetics
Roche
Illumina
Centogene
23andMe
Segment by Type
Prenatal Testing
Newborn Screening
Predictive and Presymptomatic Testing
Pharmacogenomic Testing
Segment by Application
Hospital-based Laboratories
Diagnostic Laboratories
Specialty Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Gene Test Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Test Service companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Test Service revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Gene Test Service Âé¶¹Ô´´ Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Prenatal Testing
1.2.3 Newborn Screening
1.2.4 Predictive and Presymptomatic Testing
1.2.5 Pharmacogenomic Testing
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Gene Test Service Âé¶¹Ô´´ Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital-based Laboratories
1.3.3 Diagnostic Laboratories
1.3.4 Specialty Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Test Service Âé¶¹Ô´´ Perspective (2019-2030)
2.2 Global Gene Test Service Growth Trends by Region
2.2.1 Gene Test Service Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Test Service Historic Âé¶¹Ô´´ Size by Region (2019-2024)
2.2.3 Gene Test Service Forecasted Âé¶¹Ô´´ Size by Region (2025-2030)
2.3 Gene Test Service Âé¶¹Ô´´ Dynamics
2.3.1 Gene Test Service Industry Trends
2.3.2 Gene Test Service Âé¶¹Ô´´ Drivers
2.3.3 Gene Test Service Âé¶¹Ô´´ Challenges
2.3.4 Gene Test Service Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Gene Test Service by Players
3.1.1 Global Gene Test Service Revenue by Players (2019-2024)
3.1.2 Global Gene Test Service Revenue Âé¶¹Ô´´ Share by Players (2019-2024)
3.2 Global Gene Test Service Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gene Test Service, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Gene Test Service Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Gene Test Service Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Test Service Revenue in 2023
3.5 Global Key Players of Gene Test Service Head office and Area Served
3.6 Global Key Players of Gene Test Service, Product and Application
3.7 Global Key Players of Gene Test Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Test Service Breakdown Data by Type
4.1 Global Gene Test Service Historic Âé¶¹Ô´´ Size by Type (2019-2024)
4.2 Global Gene Test Service Forecasted Âé¶¹Ô´´ Size by Type (2025-2030)
5 Gene Test Service Breakdown Data by Application
5.1 Global Gene Test Service Historic Âé¶¹Ô´´ Size by Application (2019-2024)
5.2 Global Gene Test Service Forecasted Âé¶¹Ô´´ Size by Application (2025-2030)
6 North America
6.1 North America Gene Test Service Âé¶¹Ô´´ Size (2019-2030)
6.2 North America Gene Test Service Âé¶¹Ô´´ Size by Type
6.2.1 North America Gene Test Service Âé¶¹Ô´´ Size by Type (2019-2024)
6.2.2 North America Gene Test Service Âé¶¹Ô´´ Size by Type (2025-2030)
6.2.3 North America Gene Test Service Âé¶¹Ô´´ Share by Type (2019-2030)
6.3 North America Gene Test Service Âé¶¹Ô´´ Size by Application
6.3.1 North America Gene Test Service Âé¶¹Ô´´ Size by Application (2019-2024)
6.3.2 North America Gene Test Service Âé¶¹Ô´´ Size by Application (2025-2030)
6.3.3 North America Gene Test Service Âé¶¹Ô´´ Share by Application (2019-2030)
6.4 North America Gene Test Service Âé¶¹Ô´´ Size by Country
6.4.1 North America Gene Test Service Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Gene Test Service Âé¶¹Ô´´ Size by Country (2019-2024)
6.4.3 North America Gene Test Service Âé¶¹Ô´´ Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Gene Test Service Âé¶¹Ô´´ Size (2019-2030)
7.2 Europe Gene Test Service Âé¶¹Ô´´ Size by Type
7.2.1 Europe Gene Test Service Âé¶¹Ô´´ Size by Type (2019-2024)
7.2.2 Europe Gene Test Service Âé¶¹Ô´´ Size by Type (2025-2030)
7.2.3 Europe Gene Test Service Âé¶¹Ô´´ Share by Type (2019-2030)
7.3 Europe Gene Test Service Âé¶¹Ô´´ Size by Application
7.3.1 Europe Gene Test Service Âé¶¹Ô´´ Size by Application (2019-2024)
7.3.2 Europe Gene Test Service Âé¶¹Ô´´ Size by Application (2025-2030)
7.3.3 Europe Gene Test Service Âé¶¹Ô´´ Share by Application (2019-2030)
7.4 Europe Gene Test Service Âé¶¹Ô´´ Size by Country
7.4.1 Europe Gene Test Service Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Gene Test Service Âé¶¹Ô´´ Size by Country (2019-2024)
7.4.3 Europe Gene Test Service Âé¶¹Ô´´ Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Gene Test Service Âé¶¹Ô´´ Size (2019-2030)
8.2 China Gene Test Service Âé¶¹Ô´´ Size by Type
8.2.1 China Gene Test Service Âé¶¹Ô´´ Size by Type (2019-2024)
8.2.2 China Gene Test Service Âé¶¹Ô´´ Size by Type (2025-2030)
8.2.3 China Gene Test Service Âé¶¹Ô´´ Share by Type (2019-2030)
8.3 China Gene Test Service Âé¶¹Ô´´ Size by Application
8.3.1 China Gene Test Service Âé¶¹Ô´´ Size by Application (2019-2024)
8.3.2 China Gene Test Service Âé¶¹Ô´´ Size by Application (2025-2030)
8.3.3 China Gene Test Service Âé¶¹Ô´´ Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Gene Test Service Âé¶¹Ô´´ Size (2019-2030)
9.2 Asia Gene Test Service Âé¶¹Ô´´ Size by Type
9.2.1 Asia Gene Test Service Âé¶¹Ô´´ Size by Type (2019-2024)
9.2.2 Asia Gene Test Service Âé¶¹Ô´´ Size by Type (2025-2030)
9.2.3 Asia Gene Test Service Âé¶¹Ô´´ Share by Type (2019-2030)
9.3 Asia Gene Test Service Âé¶¹Ô´´ Size by Application
9.3.1 Asia Gene Test Service Âé¶¹Ô´´ Size by Application (2019-2024)
9.3.2 Asia Gene Test Service Âé¶¹Ô´´ Size by Application (2025-2030)
9.3.3 Asia Gene Test Service Âé¶¹Ô´´ Share by Application (2019-2030)
9.4 Asia Gene Test Service Âé¶¹Ô´´ Size by Region
9.4.1 Asia Gene Test Service Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Gene Test Service Âé¶¹Ô´´ Size by Region (2019-2024)
9.4.3 Asia Gene Test Service Âé¶¹Ô´´ Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Gene Test Service Âé¶¹Ô´´ Size (2019-2030)
10.2 Middle East, Africa, and Latin America Gene Test Service Âé¶¹Ô´´ Size by Type
10.2.1 Middle East, Africa, and Latin America Gene Test Service Âé¶¹Ô´´ Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Gene Test Service Âé¶¹Ô´´ Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Gene Test Service Âé¶¹Ô´´ Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Gene Test Service Âé¶¹Ô´´ Size by Application
10.3.1 Middle East, Africa, and Latin America Gene Test Service Âé¶¹Ô´´ Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Gene Test Service Âé¶¹Ô´´ Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Gene Test Service Âé¶¹Ô´´ Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Gene Test Service Âé¶¹Ô´´ Size by Country
10.4.1 Middle East, Africa, and Latin America Gene Test Service Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Gene Test Service Âé¶¹Ô´´ Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Gene Test Service Âé¶¹Ô´´ Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 LabCorp
11.1.1 LabCorp Company Details
11.1.2 LabCorp Business Overview
11.1.3 LabCorp Gene Test Service Introduction
11.1.4 LabCorp Revenue in Gene Test Service Business (2019-2024)
11.1.5 LabCorp Recent Developments
11.2 Quest Diagnostics
11.2.1 Quest Diagnostics Company Details
11.2.2 Quest Diagnostics Business Overview
11.2.3 Quest Diagnostics Gene Test Service Introduction
11.2.4 Quest Diagnostics Revenue in Gene Test Service Business (2019-2024)
11.2.5 Quest Diagnostics Recent Developments
11.3 Genomic Health
11.3.1 Genomic Health Company Details
11.3.2 Genomic Health Business Overview
11.3.3 Genomic Health Gene Test Service Introduction
11.3.4 Genomic Health Revenue in Gene Test Service Business (2019-2024)
11.3.5 Genomic Health Recent Developments
11.4 NeoGenomics
11.4.1 NeoGenomics Company Details
11.4.2 NeoGenomics Business Overview
11.4.3 NeoGenomics Gene Test Service Introduction
11.4.4 NeoGenomics Revenue in Gene Test Service Business (2019-2024)
11.4.5 NeoGenomics Recent Developments
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Details
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Gene Test Service Introduction
11.5.4 Eurofins Scientific Revenue in Gene Test Service Business (2019-2024)
11.5.5 Eurofins Scientific Recent Developments
11.6 Ambry Genetics
11.6.1 Ambry Genetics Company Details
11.6.2 Ambry Genetics Business Overview
11.6.3 Ambry Genetics Gene Test Service Introduction
11.6.4 Ambry Genetics Revenue in Gene Test Service Business (2019-2024)
11.6.5 Ambry Genetics Recent Developments
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Gene Test Service Introduction
11.7.4 Roche Revenue in Gene Test Service Business (2019-2024)
11.7.5 Roche Recent Developments
11.8 Illumina
11.8.1 Illumina Company Details
11.8.2 Illumina Business Overview
11.8.3 Illumina Gene Test Service Introduction
11.8.4 Illumina Revenue in Gene Test Service Business (2019-2024)
11.8.5 Illumina Recent Developments
11.9 Centogene
11.9.1 Centogene Company Details
11.9.2 Centogene Business Overview
11.9.3 Centogene Gene Test Service Introduction
11.9.4 Centogene Revenue in Gene Test Service Business (2019-2024)
11.9.5 Centogene Recent Developments
11.10 23andMe
11.10.1 23andMe Company Details
11.10.2 23andMe Business Overview
11.10.3 23andMe Gene Test Service Introduction
11.10.4 23andMe Revenue in Gene Test Service Business (2019-2024)
11.10.5 23andMe Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LabCorp
Quest Diagnostics
Genomic Health
NeoGenomics
Eurofins Scientific
Ambry Genetics
Roche
Illumina
Centogene
23andMe
Ìý
Ìý
*If Applicable.
